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b2 Integrins and ICAM-1 Are Involved
in Establishment of the Intestinal
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James W. Huleatt and Leo Lefranc¸ois et al., 1994), while the a4b7 integrin primarily initiates
binding of naive lymphocytes to PP HEV via the mucosalDivision of Rheumatic Diseases
addressin MadCAM-1 (Bargatze et al., 1995; Hamann etUniversity of Connecticut Health Center
al., 1994; Tsuzuki et al., 1996). The b2 integrin LFA-1Farmington, Connecticut 06030
(CD11a) is also involved in the interaction of naive lym-
phocytes with LN and PP HEV primarily during the later
stages of arrest and diapedesis (Butcher and Picker,Summary
1996; Bargatze et al., 1995). Such selective interactions
are controlled via regulated expression of lymphocyteDevelopment of the mucosal immune system was ex-
receptors and by the array of counterreceptors ex-amined in mice with partial loss of expression of
pressed by HEV. PP HEV express low levels of L-selectinICAM-1 or CD18. Profound effects on Peyer’s patch
ligand but high levels of MAdCAM-1, thus directing the(PP), lamina propria (LP), and intraepithelial lympho-
interaction toward a4b7–MAdCAM-1 binding (Berlin etcyte (IEL) T cell populations were observed in mu-
al., 1995).tant mice. Normal expression of CD18 integrins and
The intestinal mucosa represents an integrated sys-ICAM-1 was essential for development of the CD8ab
tem of secondary lymphoid organs (PP, mesenteric LN)TCRab LP and IEL compartment and for the genera-
and mucosal effector sites (McGhee et al., 1992; Kraeh-tion of normal PP lymphocyte populations. The partial
enbuhl and Neutra, 1992). The effector sites are com-loss of CD8ab IEL correlated with the loss of TCRab
prised of lamina propria (LP) and the intraepithelial lym-IEL-mediated lytic activity. The presence of a subset
phocyte (IEL) compartment located above the villusof Thy11 TCRgd IEL was also dependent on CD18 inte-
basement membrane (McGhee et al., 1992; Kraehenbuhlgrins and ICAM-1. Both the lytic activity and the ex-
and Neutra, 1992; James, 1991; Goodman and Lefran-pression of CD11c by TCRgd IEL were up-regulated
c¸ois, 1989). With respect to trafficking to mucosal ef-in the presence of TCRab T cells. Analysis of bone
fector sites, a4b7 iscritical for entry of activated lympho-marrow chimeras demonstrated that a bone marrow–
cytes into LP (Butcher and Picker, 1996; Bargatze et al.,derived ICAM-11 accessory cell was involved in the
1995; Hamann et al., 1994). Furthermore, the relativegeneration of some TCRab IEL. These results demon-
lack of L-selectin ligand on LP venules favors entry ofstrated that ICAM-1 and b2 integrins were required for
activated versus naive lymphocytes into LP (Berlin etestablishment of a normal intestinal immune system.
al., 1995). Based on in vitro and in vivo antibody blocking
studies, b2 integrins, such as CD11a, and their ligands,
Introduction such as ICAM-1, are thought to play only a minor role
in this system (Bargatze et al., 1995; Butcher and Picker,
The trafficking of lymphocytes within the immune sys- 1996). In regard to IEL, it is not known which adhesion
tem and the selective homing of lymphocytes to specific molecules are involved in allowing IEL to traffic to the
tissues is governed primarily by adhesion molecules. intestine, traverse the basement membrane, and subse-
Continual recirculation of lymphocytes from blood to quently become tethered in the epithelium. Small intesti-
lymph in secondary lymphoid organs occurs via a nal IEL lack L-selectin and as a population appear to
multistep process in which lymphocyte receptors, pri- have low level expression of CD11a (Lefranc¸ois, 1987).
marily selectins and integrins, interact with endothelium- Interestingly, a significant subset of TCRgd and TCRab
expressed counterreceptors including vascular ad- IEL express p150,95 (axb2 or CD11c), but whether this
dressins and intercellular adhesion molecules (ICAMs; integrin is involved in homing or activation and/or target
reviewed by Springer, 1994; Butcher and Picker, 1996). cell recognition by IEL is unknown (Huleatt and Lefran-
In addition to recirculation under normal conditions via c¸ois, 1995). Small and large intestinal IEL (Kilshaw and
interactions with high endothelialvenules (HEV) of lymph Murant, 1990; Lefranc¸ois et al., 1994; Camerini et al.,
nodes (LN) and Peyer’s patches (PP), extravasation of 1993; Beagley et al., 1995; Ibraghimov and Lynch, 1994)
lymphocytes through activated vascular endothelium as well as other epithelium-associated T cells express
can occur in response to inflammation in underlying the aEb7 integrin whose ligand is E-cadherin expressed
tissues. Furthermore, lymphocyte activation results in by epithelial cells (Cepek et al., 1994; Karecla et al.,
modifications of homing receptor expression. For exam- 1995). Thus far, it is unclear whether this interaction is
ple, activated T cells generally lack L-selectin (CD62L) important for entry of IEL into the epithelium or is in-
and may up-regulate certain integrins (Dailey et al., volved in adherence of IEL to epithelial cells, although
1985), presumably to allow such cells to leave the circu- a recent report suggests that E-cadherin is not required
lation and travel to sites of inflammation. Tissue-specific for maintenance of IEL in the epithelium (Hermiston and
homing molecules also exist, such as CLA, which directs Gordon, 1995). A subset of LP T cells also lack L-selec-
memory T cell homing to skin (Berg et al., 1991). tin, suggesting that these cells, as well as IEL, have
Recirculation through peripheral LN and intestinal PP undergone prior activation (Targan et al., 1995). How-
has been studied extensively.Lymphocyte homing to LN ever, it is unknown to what extent activation of LP T
and PP utilizes distinct and overlapping mechanisms. cells and IEL occurs in situ or prior to trafficking into
Thus, L-selectin can initiate adhesion of naive lympho- the mucosa. IEL exhibit little ability to recirculate, and
only a subset of LP lymphocytes enter the recirculatingcytes to LN and PP HEV (Bargatze et al., 1995; Hamann
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lymphocyte pool (Poussier et al., 1992; Lefranc¸ois,
1994). This result indicates that the composition of T
cells in mucosal effector sites may be regulated, at least
in part, by tissue-specific factors, rather than by contin-
ual entry of cells from the common lymphocyte pool.
The activation status of T cell populations within intes-
tinal effector sites is critically dependent on the pres-
ence of luminal microbial flora. Thus, in germ-free ani-
mals, the total number of TCRab IEL and LP T cells is
decreased greatly, and these cells do not exhibit signs
of activation. For example, a hallmark of mouse TCRab
IEL activation is their constitutive lytic activity, which is
absent in germ-free mice (Goodman and Lefranc¸ois,
1989; Lefranc¸ois and Goodman, 1989; Kawaguchi et
al., 1993; Ishikawa et al., 1993). The precise antigens
responsible for intestinal T cell activation under normal
conditions are unknown. Moreover, the nature of the
antigen-presenting cell(s), APC(s), involved in activation
in vivo has not been defined. This is particularly true in
the intestinal epithelium where it has been difficult to
detect professional APCs. Although enterocytes can
present antigen in vitro (Mayer and Shlien, 1987; Mayer
et al., 1991), it is not known whether this occurs in vivo.
In light of these facts, the activation status of IEL, and
their unique pattern of b2 integrin expression, we under-
took the analysis of intestinal lymphocyte populations
in mice with a partial deficit in CD18 (Sligh et al., 1993)
or ICAM-1 (Wilson et al., 1993) expression. Previous
studies using these animals have not examined mucosal
lymphoid populations. Our findings demonstrated that
subsets of LP T cells and IEL required b2 integrins and
ICAM-1 for activation and expansion in situ. Importantly,
the activation and expansion of some TCRab IEL was
dependent on a bone marrow (BM)-derived accessory
cell, indicating that epithelium-associated APCs may be
important for T cell function in the intestinal mucosa.
Results
Expression of LFA-1 and p150,95
in CD18 Mutant Mice
Our previous results indicate that CD11c expression is Figure 1. b2 Integrin Expression by CD8 LN T Cells and IEL
related to activation of IEL in vivo, particularly for gd T
(Top) Expression of CD11a and CD11c on LN T cells and IEL from
cells (Huleatt and Lefranc¸ois, 1995). To determine normal, CD18 and ICAM-1 mutant mice. CD81 LN T cells or IEL were
whether the absence of CD11c as well as other b2 inte- examined for expression of CD11a (shaded histograms) or CD11c
grins or their ligands would affect IEL development and/ (open histograms) using MAb M17/4 or MAb N418, respectively.
Histograms reflect fluorescence intensity of CD8a1 gated lympho-or activation, we analyzed IEL and LN T cells from mice
cytes, and the solid vertical line discriminates between negative andwith disruptions in the genes encoding CD18 or ICAM-1.
positive staining as determined by control staining. FluorescenceIn both of these mouse lines, the disruption of expres-
intensity is presented on a four-decade log scale.
sion of the targeted genes is incomplete. Because of a (Bottom) High level expression of CD11a by CD8b1 IEL. TCRgd (A)
cryptic transcriptional start site in the targeting con- or TCRab IEL (B) were tested for CD11a expression by fluorescence
struct, CD18 can be expressed in certain situations, flow cytometry. TCRab IEL were analyzed by three color cytometry
for expression of CD8a and CD11a (C) or CD8b and CD11a (D).such as after activation of neutrophils with PMA (Wilson
et al., 1993). In the case of the ICAM-1 mutant animals,
splice variantsof ICAM-1 have been identified that could
potentially interact with LFA-1 and other counterrecep- of CD11a and lacked CD11c. Interestingly, IEL from nor-
mal mice were largely negative for CD11a expressiontors (King et al., 1995). However, a detailed examination
of lymphocyte populations in these mice has not been but contained a population of CD11ahigh cells that were
absent in IEL from ICAM-1mut mice (Figure 1, top). CD11cperformed. CD81 LN T cells from normal mice and from
ICAM-1mut mice expressed homogeneously high levels was expressed by IEL from normal and ICAM-1mut mice
at similar levels, but there were fewer CD11c1 cells inof CD11a and lacked CD11c (Figure 1, top). However,
CD81 LN T cells from CD18mut mice expressed low levels ICAM-1mut (40%) versus control IEL (60%). In contrast,
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CD18mut IEL lacked detectable CD11a and CD11c ex- As shown in Figure 2D, three subsets of TCRab IEL
were detected in normal mice: CD8a1b2, CD8a1blow, andpression. Thus, although the CD18 gene disruption was
incomplete and allowed low expression of CD11a by LN CD8a1bhigh. Since a population of TCRab IEL that ex-
pressed low levels of CD8b had not been describedT cells, b2 integrin expression was not evident on IEL.
To determine the subset composition of the CD11ahigh previously, we wished to ensure that the staining was
not artifactual and to assess quantitatively the effectcells observed in normal IEL (Figure 1, bottom), we per-
formed three-color flow cytometry (Figure 1, bottom). of partial loss of b2 integrin or ICAM-1 on the various
subsets. As a negative control, IEL from mice lackingOnly 10% of TCRgd IEL expressed low levels of CD11a
(Figure 1A), while 58% of TCRab IEL had high CD11a CD8b expression by virtue of a targeted disruption of the
CD8b gene were analyzed and CD8b was undetectablelevels (Figure 1B). When TCRab IEL were analyzed for
expression of CD11a in conjunction with expression of (Figure 3A). TCRab IEL from normal mice contained 20%
CD8bhigh and 8% CD8blow cells. In contrast, IEL fromCD8a (Figure 1C) or CD8b (Figure 1D), an interesting
pattern emerged. CD8ahigh cells expressed high levels CD18mut and ICAM-1mut mice contained z1% CD8bhigh
and 8%–10% CD8blow cells, indicating a nearly completeof CD11a, and as shown in Figure 1D, the CD11ahigh
subset also expressed CD8b. Thus, the highest levels block in generation of the CD8bhigh subset in these mice
(Figure 3). Although at present the significance ofof expression of CD11a were present on TCRab CD8ab
IEL, while CD8aa IEL, regardless of TCR type, were CD8b low IEL is unknown, neither b2 integrins or ICAM-1
were necessary for their production.CD11alow or CD11a2. This result was confirmed by sam-
ples in which CD8a, CD8b, and CD11a were analyzed
simultaneously (data not shown). A population of CD82 Abnormal Development of LP and PP T Cell
cells comprising CD41 CD82 IEL were also CD11ahigh Populations in CD18mut and ICAM-1mut Mice
(Figure 1; data not shown). The LP underlying the villus basement membrane is a
rich source of mucosal T cells, B cells, and IgA-produc-
Disruption of CD18 or ICAM-1 Expression ing plasma cells. To determine whether the changes we
Results in Loss of IEL Subsets observed in IEL extended to the LP, we tested LP T
For comparison to mucosal T cells, LN cells from cells from CD18mut and ICAM-1mut mice. In theexperiment
CD18mut, ICAM-1mut, and normal age-matched mice were shown (1 of 3 with similar results), normal LP TCRab
analyzed. There was a reproducible decrease of z20% cells were made up of 63% CD4 and 30% CD8 cells,
of total LN T cells inCD18mut mice and a small butconsis- establishing a 2:1 CD4:CD8 ratio (Figure 4A). A minor
tent loss of 5%–10% of total LN T cells in ICAM-1mut subset (7%) of CD42 CD82 cells was also detected. In
mice as compared with values from normal control mice, contrast, CD4:CD8 ratios in CD18mut and ICAM-1mut mice
although total LNcell numbers didnot differ appreciably, were z5:1 and z4:1, respectively (Figures 4B and 4C).
and most non-T cells were sIg1 (data not shown). The Thus, CD81 T cells were depleted significantly in LP as
CD4/CD8 composition of LN T cells was unaffected in a result of partial loss of CD18 or ICAM-1. To determine
CD18mut or ICAM-1mut mice, and CD81 T cells in each of whether the composition of CD81 LP T cells was affected
the strains expressed normal levels of the CD8b chain by the mutations, CD8b expression was analyzed on
(data not shown). A more dramatic effect of partial loss CD8a1 LP TCRab cells. While normal CD81 LP T cells
of CD18/ICAM-1 was detected in the IEL compartment. all bore CD8b (Figure 4D), 23% of CD18mut and 53% of
In general, there was a 1.5- to 2-fold decrease in total ICAM-1mut LP T cells lacked CD8b (Figures 4E and 4F).
IEL in CD18mut and ICAM-1mut mice as compared with We also examined the role of CD18 or ICAM-1 on
controls. This decrease represented a loss of TCRgd PP lymphocyte development. PP from ICAM-1mut and
and TCRab IEL (data not shown). In terms of percentage, CD18mut mice contained 3- to 5-fold fewer lymphocytes
IEL from CD18mut and ICAM-1mut mice contained on aver- overall (including T and B cells) as compared with PP
age z1/3 fewer TCRab T cells (Figures 2A–2C). A striking from control mice. Furthermore, the percentage of T
result was obtained when subset analysis of IEL was cells was decreased z3-fold in mutant mice but, unlike
performed. Whereas 26% of normal TCRab IEL ex- in the LP, the CD4:CD8 ratio remained normal (data not
pressed CD8b (Figure 2D), this subset was reduced to shown). These results were consistent with previous
11%and 8% in CD18mut and ICAM-1mut mice, respectively reports that demonstrated a role for CD11a/ICAM-1 dur-
(Figures 2E and 2F). Coincident with the loss of CD8b1 ing entry of lymphocytes into PP (Bargatze et al., 1995)
cells was a reduction in Thy11 TCRab IEL, with 22% of and with the possibility of integrin-mediated activation
normal TCRab IEL bearing Thy1 but only 5% of CD18mut
and expansion of lymphocytes within PP.
and 11% of ICAM-1mut IEL expressing primarily low levels
of Thy1. Since the role of b2 integrins in TCRgd T cell
CD18 Integrin and ICAM-1 Requirementsdevelopment and activation had not been tested pre-
in Induction of IEL Lytic Activityviously, we analyzed TCRgd IEL in ICAM-1mut and CD18mut
Freshly isolated IEL exhibit constitutive cytolytic activitymice. While 32% of normal TCRgd IEL were Thy11, only
as measured in a redirected lysis assay using target7% and 12% Thy11 cells were detected in CD18mut and
cells bearing Fc receptors cross-linked with IEL via anti-ICAM-1mut IEL, respectively (Figures 2J–2L). Given our
TCR monoclonal antibodies (MAbs) (Lefranc¸ois andprevious demonstration that the presence of Thy11 IEL
Goodman, 1989; Goodman and Lefranc¸ois, 1989). Acti-is dependent on activation due to colonization of the
vation of IEL via interactions with bacteria or their prod-gut by bacterial flora (Lefranc¸ois and Goodman, 1989),
ucts is required to induce this activity since TCRab IELthese results implied that such activation required b2
integrin interaction with ICAM-1. from germ-free mice lack this activity (Lefranc¸ois and
Immunity
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Figure 2. Generation of Thy11 and CD8ab IEL Is Blocked in CD18 or ICAM-1 Mutant Mice
IEL from C57BL/6, CD18mut, and ICAM-1mut mice were isolated, purified by panning with anti-CD8 MAb, and examined for expression of TCRab
(A–C). TCRab1 IEL from each of the strains were analyzed for expression of CD8a and CD8b (D–F) and CD8a versus Thy1 (G–I). TCRgd1 IEL
were analyzed for expression of CD8a versus Thy1 (J–L). Fluorescence intensity is displayed on a four-decade log scale.
Goodman, 1989; Kawaguchi et al., 1993). Our results lytic activity in TCRab IEL would not be expected (Le-
franc¸ois and Goodman, 1989; see below). An interestingthus far suggested that the activation and expansion of
TCRab and TCRgd IEL subsets were dependent on b2 result was obtained when the cytolytic activity of IEL
from ICAM-1mut animals was tested. ICAM-1mut IEL exhib-integrins and ICAM-1. As a furthermeasure of activation,
we measured lytic activity in IEL from CD18mut and ICAM- ited minimal cytolytic activity against target cells coated
with MAbs specific for CD3 or TCRab, again reflecting1mut mice. IEL from C57BL/6 mice exhibited significant
cytolytic activity against target cells bearing MAbs with the loss of Thy11 CD8ab cells. Surprisingly, however,
TCRgd IEL from these animals exhibited normal levelsspecificity for CD3, TCRab, or TCRgd (Figure 5). In
marked contrast, IEL from CD18mut mice exhibited no of cytolytic activity when lysis was induced by an anti-
TCRgd MAb, but not when lysis was induced by an anti-detectable cytolytic activity in any case. Since anti-
CD11a MAbs can inhibit redirected lytic activity of T cell CD3 MAb (Figures 5B and 5C). This result suggested
that CD3-mediated signal transduction via TCRgd wasclones (Hua et al., 1985; Hoffman et al., 1985), the loss
of activitymay be related to theabsence of CD18. Never- distinct from that of TCRab IEL. Taken together, the
results demonstrated that b2 integrins and ICAM-1 weretheless, in the absence of Thy11 CD8bhigh TCRab IEL,
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Figure 3. Defective CD18 or ICAM-1 Expres-
sion Results in Block of Development of
TCRab1 CD8abhigh IEL
Expression of CD8b was examined by three-
color fluorescence flow cytometry on IEL iso-
lated from the indicated mouse strains. IEL
were stained with FITC-conjugated anti-
TCRab MAb H57.597, PE-conjugated anti-
CD8a, and biotinylated anti-CD8b MAb. Ex-
pression of CD8b was detected following
secondary staining with streptavidin–red
670.Histograms show expression of CD8b by
TCRab1 CD8a1 IEL. Fluorescence intensity is
displayed on a four-decade log scale.
required for activation and expansion of CD8ab TCRab CD3-Mediated Signaling Is Distinct
in TCRgd versus TCRab IELIEL. Similarly, the generation of a significant portion of
Thy11 TCRgd IEL required b2 integrins and ICAM-1, but IEL from ICAM-1mut mice exhibited normal cytolytic activ-
ity against anti-TCRgd, but not against anti-CD3 or anti-induction of TCRgd IEL lytic activity was apparently
ICAM-1 independent. TCRab bearing targets (Figure 5), suggesting a possible
Figure 4. Aberrant Generation of TCRab1
CD8ab1 Lymphocytes Occurs in LP of
CD18mut and ICAMmut Mice
TCRab1 LP lymphocytes from C57BL/6 (A
and D), CD18mut (B and E), and ICAM-1mut (C
and F) mice were analyzed for expression of
CD8a and CD4 or CD8b by three-color fluo-
rescence flow cytometry. Fluorescence in-
tensity is displayed on a four-decade log
scale.
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Figure 5. IEL from CD18mut and ICAM-1mut Mice Exhibit Distinct Im-
pairments in Cytolytic Activity
Cytolytic activity of serially diluted IEL isolated from C57BL/6
(squares), CD18mut (circles), and ICAM-1mut (triangles) mice was mea-
sured against FcR1 P815 target cells in a 6 hr 51Cr-release assay as Figure 6. Optimal Activation of TCRgd IEL Requires TCRab T Cells
described in Experimental Procedures. P815 cells were preincu- (Top) CD3 cross-linking is ineffective in triggering TCRgd IEL cyto-
bated with either anti-TCRab MAb (A), anti-TCRgd MAb (B), or anti- lytic activity. The cytolytic activity of freshly isolated IEL from
CD3e MAb (C). Effector to target ratios reflect corrected values TCRd2/2 or TCRb2/2 mice was examined against 51Cr-labeled P815
based on the absolute number of TCRab1 (A), TCRgd1 (B), or CD31 cells bearing either anti-TCRab (H57.597, circles), anti-TCRgd (GL4,
(C) IEL in the assay as determined by fluorescence flow cytometry. triangles), or anti-CD3e (145-2C11, squares) MAbs. Assay length
was 6 hr.
(Bottom) TCRab T cells are required for efficient induction of CD11c
expression by TCRgd IEL. CD11c expression by gated TCRgd ordichotomy in the ability of CD3 tomediate TCR triggering
TCRab IEL from C57BL/6 (A and B), TCRd2/2 (C), or TCRb2/2 (D)in TCRab versus TCRgd IEL. To test this hypothesis,
mice was assessed by fluorescence flow cytometry.anti-CD3-mediated cytolytic activity was examined in
freshly isolated IEL from either TCRd2/2 or TCRb2/2 mice
(Figure 6, top). Cytolytic activity of TCRab IEL from bearing anti-TCRgd MAb, but not against targets bear-
ing anti-TCRab. In contrast with TCRab IEL, lytic ac-TCRd2/2 mice was identical against targets bearing anti-
CD3 or anti-TCRab MAbs, with negligible killing of tar- tivity of TCRgd IEL was poorly induced by anti-CD3
MAb, indicating that the results obtained with IEL fromgets bearing anti-TCRgd MAb. Similarly, TCRgd IEL from
TCRb2/2 mice exhibited cytolytic activity against targets ICAM-1mut mice (Figure 5) were due to a general property
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Figure 7. Expression of ICAM-1 on Cells
Originating in the BM Is Necessary for Effi-
cient Expansion of TCRab IEL
Lethally irradiated C57BL/6 (Ly5.1) (A, D, and
G), ICAM-1mut (Ly5.1) (B, E, and H), or B6-Ly5.2
(C, F, and I) mice were reconstituted with 5 3
106 BM cells isolated from either B6-Ly5.2 or
ICAM-1mut (Ly5.1) mice as indicated; 20 weeks
after reconstitution donor origin lymphocytes
were analyzed by three-color fluorescence
flow cytometry for expression of TCRab ver-
sus the following: CD8a (A–C), CD8b (D–F),
and CD4 (G–I). Analysis was performed on
gated donor origin cells based on the expres-
sion of Ly5.1 or Ly5.2. Fluorescence intensity
is displayed on a four-decade log scale.
of TCRgd IEL. Moreover, the generally low lytic activity ICAM-1mut mice as hosts (Figure 7). C57BL/6-Ly5.2 mice
were used as donors or hosts to allow detection of BM-of TCRgd IEL from TCRb2/2 mice was in contrast with
TCRgd IEL lytic activity from normal or ICAM-1mut mice derived cells. Reconstitution of C57BL/6 or ICAM-1mut
mice with normal BM resulted in normal development(Figure 5). This was a consistent finding using IEL from
these and other TCRab-deficient mice. Thus, in addition of all IEL subsets (Figure 7). No significant difference
was noted in the appearance of CD8ab TCRab IEL into the distinction in triggering via CD3 demonstrated by
these findings, the results further indicated that TCRab ICAM-1mut or normal hosts, indicating that expression of
ICAM-1 by radiation-resistant cells was not required forT cells, perhaps CD8b2 IEL, were necessary for induc-
tion of maximum lytic activity in TCRgd IEL. development of this subset (Figures 7D and 7E). How-
ever, reconstitution of normal hosts with ICAM-1mut BM,To explore further the apparent defect in TCRgd IEL
activation in mice lacking TCRab T cells, the expression resulted in dramatic effects on TCRab IEL. Total TCRab
IEL were reduced z3-fold in these mice (Figure 7C, 7F,of b2 integrins on IEL from TCR-deficient mice was ex-
amined. CD11c expression by TCRab IEL from normal and 7I) owing to a reduction in CD8 and CD4 cells,
including a z3- to 4-fold decline in CD8b1 cells. Theor TCRd2/2 mice was similar with 49% of normal and
64% of TCRd2/2 IEL bearing CD11c (Figure 6, bottom). total number of IEL isolated from each of the mice re-
flected the lossof TCRabcells. This result demonstratedHowever, while CD11a expression of TCRgd IEL from
TCRb2/2 mice was comparable to that of IEL from normal that a BM-derived ICAM-11 cell, potentially an APC, was
responsible for the generation of a significant portionmice (data not shown), CD11c expression was severely
diminished as compared with control levels. Thus, 60% of TCRab IEL.
of control TCRgd IEL bore CD11c, while only 24% of
TCRb2/2 IEL expressed low levels of CD11c. These re- Discussion
sults suggested that TCRab T cells were necessary for
up-regulation of TCRgd IEL lytic activity and CD11c ex- The results presented identified a critical role for b2
pression and further implied that CD11c may be the b2 integrins and ICAM-1 in establishment of the inductive
integrin involved in TCRgd IEL activation. and effector sites of the intestinal mucosal immune sys-
tem. Partial disruption of b2 integrin or ICAM-1 expres-
sion resulted in profound effects on lymphocytes withinBM Origin of ICAM-11 Cell Responsible
for TCRab IEL Generation the PP, LP and intestinal epithelium. Therefore, it is pos-
sible that complete disruption of ICAM-1 or CD18 ex-To determine whether the ICAM-11 accessory cell that
was involved in IEL activation and expansion was BM- pression would result in more severe defects, but this
remains to be tested. The effects observed were mani-derived or was a radiation-resistant stromal cell (i.e.,
intestinal epithelial cells), we constructed radiation BM fest in the nearly complete loss of TCRab Thy11 CD8bhigh
IEL, in addition to a large reduction of this subset in LP.chimeras using either ICAM-1mut BM or normal BM and
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PP lymphocytes exhibited a more generalized defect cells, although, interestingly, ICAM-1 was not needed
for expansion of LN T cells (Gonzalo et al., 1995). Itexemplified by an overall decrease in lymphocytes. In
addition, Thy11 TCRgd IEL were reduced dramatically had been thought that the only potential APC within
the epithelium were enterocytes, but a recent reportin CD18mut and ICAM-1mut mice. Our previous results indi-
cate that the Thy11 IEL subset contains constitutively demonstrates that dendritic cells (DC) reside above the
intestinal basement membrane within the epithelium ofactivated T cellsas assessed by inductionof lyticactivity
(Lefranc¸ois and Goodman, 1989). Furthermore, gnotobi- the rat (Maric et al., 1996). Thus, our demonstration that
a BM-derived ICAM-11 cell was involved in generationotic mice contain few Thy11 IEL reflecting a loss of
TCRgd cells and TCRab CD8b1 IEL (Lefranc¸ois and of some TCRab IEL was consistent with IEL interacting
directly with ICAM-11 DC in the epithelial compartment,Goodman, 1989). Thus, the presence of normal flora
results in the development of Thy11 IEL, including resulting in their activation and expansion. Another pos-
sibility that cannot be ruled out is that TCRab CD8b1 TTCRab CD8b1 IEL, and our results suggested that this
process required interactions between CD18 integrins cells activated in the LP traverse the basement mem-
brane and become IEL. However, data from parabioticand ICAM-1.
The partial loss of CD8ab IEL and LP T cells in CD18mut mice (Poussier et al., 1992; Lefranc¸ois, 1994) suggest
that this pathway may not be operational. These studiesand ICAM-1mut mice was consistent with a block in T
lymphocyte development, impaired trafficking of lym- show that there is little entry of peripheral T cells into
the IEL compartment while z70% of the LP cells arephocytes from the periphery into the mucosa, or defec-
tive activation and subsequent expansion of CD8ab part of the recirculating lymphocyte pool. Thus, either
IEL are not derived from LP or they are derived from thecells in situ. In regard to development, addition of anti-
LFA-1 or anti-ICAM-1 MAb to fetal thymus organ cul- portion of LP that do not recirculate. Based on limited
data, the possibility that some IEL are derived from PPtures inhibits the differentiation of thymocytes from the
CD42 CD82 to CD41 CD81 stage (Fine and Kruisbeek, cells has also been proposed (Guy-Grand et al., 1978).
Although PP T cells were decreased in ICAM-1mut and1991). However, the loss of normal ICAM-1 expression
in the animals used here (Sligh et al., 1993), the lack of CD18mut mice, this loss was not specific to any subset,
and along with the data from parabiotic mice, does notICAM-1 in another mutant mouse line (Xu et al., 1994),
and disruption of the CD11a gene (Schmits et al., 1996) support the hypothesis that IEL are derived from PP. In
addition, in aly/aly mice that lack lymph nodes and PP,do not result in a block of T cell development, since
thymocyte development appears phenotypically normal CD8b1 IEL are normal (Nanno et al., 1994). It remains
possible that a minor fraction of TCRab CD8b1 IEL arein all of these animals (Sligh et al., 1993; Xu et al., 1994;
Schmits et al., 1996; data not shown). Therefore, either derived from the peripheral pool after activation, but the
bulk of TCRab CD8b1 IEL are probably generated viaother adhesion molecules substitute for ICAM-1 and
CD11a or antibody blocking exerts other effects on T in situ expansion. The relevant interaction in this sce-
nario was likely to involve CD11a and ICAM-1, sincecell development that are not reflected when ICAM-1 or
CD11a are absent in vivo. It seems unlikely that the loss CD11a was expressed at high levels by the CD8ab
TCRab IEL subset (Figure 1B) and MAC-1 is not ex-of specific IEL and LP subsets in mice with defective
expression of ICAM-1/CD18 was the result of a selective pressed by IEL (Huleatt and Lefranc¸ois, 1995). However,
we cannot rule out the possibility that CD11c–ICAM-1block in development. The available data also argue
against an inhibition of trafficking into LP and IEL as a interactions are important, since a recent report sug-
gests that ICAM-1 may be a ligand for the CD11c/b2result of ICAM-1/CD18 mutations. In particular, the BM
origin of the ICAM-11 accessorycell necessary for devel- integrin (Blackford et al., 1996). Finally, it is possible that
ICAM-1 expressed by T cells was involved in activationopment of at least a subset of TCRab IEL demonstrated
that the defect was not due only to impaired lympho- (Chirathaworn et al., 1995). However, the fact that we
obtained similar results using CD18mut mice and thatcyte–endothelial cell interactions. In addition, the migra-
tion of lymphocytes into the gut-associated lymphoid ICAM-1mut T cells activate normally in vitro (Sligh et al.,
1993; Xu et al., 1994) makes this an unlikely scenario.tissues, exclusive of the PP, is mediated predominantly
by interactions between the a4b7 integrin on T cells and The requirements for activation of TCRgd cells in vivo
are largely unknown. Partial CD18 deficiency resultedMadCAM-1 on endothelium and not by CD11a–ICAM
interactions (Bargatze et al., 1995; Hamann et al., 1994; in a substantial loss within the Thy11 TCRgd IEL subset
and impaired ICAM-1 expression resulted in a partialButcher and Picker, 1996). Nevertheless, since up-regu-
lation of a4b7 is necessary for activated T cell binding depletion of Thy11 cells, but did not result in loss of lytic
activity. These results suggested that ICAM-1 may beto LP venules (Bargatze et al., 1995), loss of peripheral
T cell activation could potentially be responsible for the involved in development of a subset of TCRgd IEL, but
was not required for induction of lytic activity. The lowobserved phenotype as a result of decreased entry of
activated T cells into the intestinal mucosa. In the case expression of CD11a on TCRgd IEL (Figure 1; Chao et
al., 1994) implied that this integrin was not involved inof PP, the overall decrease in B and T cells may be more
related to a loss of homing to that site rather than a TCRgd IEL activation. We also observed a large and
reproducible difference in the lytic activity of TCRgdgeneralized decline in in situ activation.
Our data are consistent with the possibility that IEL isolated from normal, ICAM-1mut, and TCRb2/2 mice,
suggesting that effective activation of TCRgd IEL re-TCRab CD81 LP T cells and IEL were activated in situ
and subsequently underwent clonal expansion. This quiredTCRab cells, perhaps IEL. Conversely, it has been
shown that TCRgd cells (not necessarily IEL) act in regu-possibility is supported by the requirement for ICAM-1
in superantigen-induced clonal expansion of splenic T lating TCRab IEL responses (Kaufmann et al., 1993).
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and Tonegawa (Massachusetts Institute of Technology, Cambridge,In addition, the presence of TCRab T cells enhanced
MA) and were maintained in our colony on a C57BL/6 background.profoundly CD11c expression on TCRgd IEL, suggesting
Mice were maintained in microisolator housing and received auto-that the effects observed on TCRgd IEL could be the
claved food and water.
indirect result of effects on TCRab T cells. Furthermore,
the facts that CD11a expression by TCRgd IEL was very MAbs
low and that MAC-1 is not expressed by TCRgd IEL The following MAbs were used in this study: GL3 and GL4, anti-
TCRgd (Goodman and Lefranc¸ois, 1989); H57.597, anti-TCRab(Huleatt and Lefranc¸ois, 1995) suggest that CD11c may
(Kubo et al., 1989); 3.168 and 53-6.7, anti-CD8a (Sarmiento et al.,be the b2 integrin involved in TCRgd IEL activation. Alter-
1980); 53-5.8 and H35-17-2, anti-CD8b (Golstein et al., 1982); anti-natively, the newly described b2 integrin, CD11d (Van
Thy1; anti-CD4; M17/4.4 and 2D7, anti-LFA-1 (Sanchez-Madrid et
der Vieren et al., 1995), or other as yet undescribed al., 1982); M1/70, anti-MAC-1 (Sanchez-Madrid et al., 1982); and
b2 integrins may be involved in TCRgd IEL activation. 3E2, anti-ICAM-1; were obtained from PharMingen (San Diego, CA)
Another interesting finding was the demonstration that as fluorochrome conjugates; N418, anti-CD11c (Metlay et al., 1990)
and 2E6, anti-b2 integrin (Metlay et al., 1990) were obtained fromTCRgd IEL lytic activity was triggered efficiently by anti-
ATCC (Rockville, MD).TCRgd but poorly by anti-CD3 MAbs (Figures 5 and
6). In contrast, anti-CD3 MAb efficiently induced lytic
Isolation of IEL
activity in TCRab IEL. The molecular basis for this differ- IEL were isolated essentially as described previously (Goodman and
ence is not clear, but could be due to the use of the Lefranc¸ois, 1988). In brief, the small intestines of individual mice
FceRIg chain in the CD3 complex of TCRgd IEL, but not were cut into 5 mm pieces and washed twice with medium. The
washed intestinal pieces were stirred at 378C for 20 min. in mediumin CD3 of TCRab CD8b1 IEL (Guy-Grand et al., 1994).
with the addition of 1 mM dithioerythritol. This step was repeated,Overall, our results indicated a pivotal role for CD18
and the resultant supernatants were rapidly filtered through nylonintegrins and ICAM-1 in homeostasis of the intestinal
wool, and the filtrate was centrifuged through a 44%/67.5% Percoll
immune system. A significant portion of the chronic acti- gradient. The cells at the interface of the Percoll gradient were
vation observed in IEL and LP TCRab T cell populations collected and prepared for flow cytometry. In some cases, panning
appears to be mediated in part via CD11a–ICAM-1 inter- of Percoll-fractionated IEL on anti-CD8 MAb-coated plates was per-
formed to remove contaminating epithelial cells.actions presumably in conjunction with TCR-mediated
MHC-antigen recognition. Although our data were con-
Isolation of LN Cellssistent with a scenario in which in situ activation and
Inguinal, brachial, cervical, and mesenteric lymph nodes were re-expansion resulted in establishment of the CD8 mucosal
moved and pooled and single cell suspensions were prepared using
effector T cell compartment, the precise identity of the a tissue homogenizer. The resulting preparation was filtered through
relevant APC(s) remains an important question. While Nytex and the filtrate centrifuged to pellet the cells.
intestinal epithelial cells (IEC) have APC function in vitro
Isolation of LP and PP Lymphocytes(Mayer and Shlien, 1987; Li et al., 1995), it is unclear
LP lymphocytes were isolated using a modified version of the proto-whether IEC can process and present antigen in vivo.
cols published by Poussier et al. (1992) and Kramer and CebraInterestingly, human IEC preferentially activate CD81 T
(1995). Following IEL isolation, the remaining epithelial cells were
cells that can exert suppressor function (Li et al., 1995). removed by stirring the intestinal pieces in 1.3 mM EDTA in Ca21-
Since IEL are poorly responsive in vitro to proliferative and Mg21-free HBSS at 378C for 30 min. This was repeated, and
signals (Gramzinski et al., 1993; Sydora et al., 1993), both supernatants discarded. Gut pieces were then stirred in RPMI
1640 media containing 5% FCS at 228C for 20 min until clear, andperhaps following antigen-specific activation via inter-
any released cells were discarded. LP lymphocytes were releasedaction with an ICAM-11 APC, further interaction with IEC
from the tissue by double digestion with 100 U/ml collagenase (Liferesults in dampeningof the proliferative response. Since
Technologies) in RPMI supplementedwith 1 mM CaCl2, 1 mM MgCl2,normal human and mouse small and large intestinal IEC and 5% FCS at 378C for 30 min. Released cells were pooled, washed
lack ICAM-1 in vivo (Bloom et al., 1995; data not shown) in PBS containing 5% FCS, then subjected to Percoll fractionation as
as well as the costimulatory molecule B7 (Bloom et al., described above for isolation of IEL. PP lymphocytes were isolated
using the method described by Lefranc¸ois and Lycke (1996).1995), it seems unlikely that IEC function as conventional
APC. IEC may, however, be important in antigen presen-
Immunofluorescence Analysistation via nonclassical MHC, such as CD1 (Bleicher et
Lymphocytes were resuspended in PBS, 0.2% BSA, 0.1% NaN3al., 1990; Panja et al., 1993; Hershberg et al., 1990; Balk (PBS/BSA/NaN3) at a concentration of 1 3 106–1 3 107 cells/ml
et al., 1994), as well as in antigen presentation to CD4 followed by incubation at 48C for 30 min with 100 ml of properly
or TCRgd T cells. In any case, continuing to define the diluted MAb. The MAbs were either directly labeled with fluorescein
isothiocyanate (FITC), phycoerythrin (PE), or were biotinylated. Formolecular interactions of mucosal T cells with IEC and
the latter, avidin–phycoerythrin (Av–PE) or avidin-Red 670 (Av-R670;intestinal APC will be important for understanding induc-
BRL Life Technologies, Gaithersburg, MD) were used as secondarytion of mucosal immunity or tolerance via oral vacci-
reagents for detection. After staining, the cells were washed twice
nation. with PBS/BSA/NaN3 andfixed in 3% paraformaldehyde buffer. Rela-
tive fluorescence intensities were then analyzed with a FACScan
(Becton-Dickinson, San Jose, CA) using standard Lysys II software.Experimental Procedures
All histograms and contour maps were plotted using a four-decade
log scale.Mice
Male and female 8- to 20-week-old C57BL/6J (B6), C57BL/6J-
Itgb2tm1Bay (CD18mut), and C57BL/6J-Icam1tm1Bay (ICAM-1mut) mice were Measurement of Cytolytic Activity
Cytolytic activity of IEL was measured using a redirected lysis assayobtained from Jackson Laboratories (Bar Harbor, ME). C57BL/
6-Ly5.2 mice (B6-Ly5.2) were obtained from Harlan. Mice harboring as previously described (Lefranc¸ois and Goodman, 1989). In brief,
cells obtained following panning on anti-CD8 MAb-coated platesa homozygous germline disruption of the CD8b gene were provided
by Dr. Dennis Loh (Washington University, St. Louis, MO). TCRd2/2 were assayed for cytolytic activity against [51Cr]sodium chromate–
labeled P815 (DBA/2 mastocytoma) target cells in the presence orand TCRb2/2 mice were originally obtained from Drs. Mombaerts
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absence of 1 mg/ml anti-CD3 (145-2C11), anti-TCRab (H57.957), Chao, C.C., Sandor, M., and Dailey, M.O. (1994). Expression and
regulation of adhesion molecules by gd T cells from lymphoid tissuesor anti-TCRgd (GL4) MAbs. Serial dilutions of effector cells were
incubated in 96-well round bottom microtiter plates with 2 3 103 and intestinal epithelium. Eur. J. Immunol. 24, 3180–3187.
target cells for 6 hr at 378C. Percent-specific lysis was calculated Chirathaworn, C., Tibbetts, S.A., Chan, M.A., and Benedict, S.H.
as 100 3 [(c.p.m. released with effectors) 2 (c.p.m. released alone)] / (1995). Cross-linking of ICAM-1 on T cells induces transient tyrosine
[(c.p.m. released by detergent) 2 (c.p.m. released alone)]. Spontane- phosporylation and inactivation of cdc2 kinase. J. Immunol. 155,
ous release in all experiments was <15%. 5479–5482.
Dailey, M.O., Gallatin, W.M., and Weissman, I.L. (1985). The in vivoProduction of BM Chimeras
behavior of T cell clones:altered migration dueto loss of the lympho-Irradiated (900 rad) C57BL/6 (Ly5.1), B6-Ly5.2, or ICAM-1mut (Ly5.1)
cyte surface homing receptor. J. Mol. Cell. Immunol. 2, 27–36.mice at 8 weeks of age were injected intravenously with 5 3 106
Fine, J.S., and Kruisbeek, A.M. (1991). The role of LFA-1/ICAM-1anti-Thy1 plus complement-treated B6-Ly5.2 or ICAM-1mut BM cells.
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